[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Newborn Genetic Testing-EMEA Market Status and Trend Report 2013-2023

March 2018 | 133 pages | ID: NB829AA08CAMEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Newborn Genetic Testing-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Newborn Genetic Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Newborn Genetic Testing 2013-2017, and development forecast 2018-2023
Main market players of Newborn Genetic Testing in EMEA, with company and product introduction, position in the Newborn Genetic Testing market
Market status and development trend of Newborn Genetic Testing by types and applications
Cost and profit status of Newborn Genetic Testing, and marketing status
Market growth drivers and challenges

The report segments the EMEA Newborn Genetic Testing market as:

EMEA Newborn Genetic Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa

EMEA Newborn Genetic Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Techniques
Polymerase Chain Reaction (PCR)
Fluorescence In-Situ Hybridization (FISH)
Array-Comparative Genomic Hybridization (aCGH)

EMEA Newborn Genetic Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinics
Hospitals
Laboratories
Other

EMEA Newborn Genetic Testing Market: Players Segment Analysis (Company and Product introduction, Newborn Genetic Testing Sales Volume, Revenue, Price and Gross Margin):
Agilent Technologies
Bio-Rad Laboratories
Illumina
Sequenom

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEWBORN GENETIC TESTING

1.1 Definition of Newborn Genetic Testing in This Report
1.2 Commercial Types of Newborn Genetic Testing
  1.2.1 Techniques
  1.2.2 Polymerase Chain Reaction (PCR)
  1.2.3 Fluorescence In-Situ Hybridization (FISH)
  1.2.4 Array-Comparative Genomic Hybridization (aCGH)
1.3 Downstream Application of Newborn Genetic Testing
  1.3.1 Clinics
  1.3.2 Hospitals
  1.3.3 Laboratories
  1.3.4 Other
1.4 Development History of Newborn Genetic Testing
1.5 Market Status and Trend of Newborn Genetic Testing 2013-2023
  1.5.1 EMEA Newborn Genetic Testing Market Status and Trend 2013-2023
  1.5.2 Regional Newborn Genetic Testing Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Newborn Genetic Testing in EMEA 2013-2017
2.2 Consumption Market of Newborn Genetic Testing in EMEA by Regions
  2.2.1 Consumption Volume of Newborn Genetic Testing in EMEA by Regions
  2.2.2 Revenue of Newborn Genetic Testing in EMEA by Regions
2.3 Market Analysis of Newborn Genetic Testing in EMEA by Regions
  2.3.1 Market Analysis of Newborn Genetic Testing in Europe 2013-2017
  2.3.2 Market Analysis of Newborn Genetic Testing in Middle East 2013-2017
  2.3.3 Market Analysis of Newborn Genetic Testing in Africa 2013-2017
2.4 Market Development Forecast of Newborn Genetic Testing in EMEA 2018-2023
  2.4.1 Market Development Forecast of Newborn Genetic Testing in EMEA 2018-2023
  2.4.2 Market Development Forecast of Newborn Genetic Testing by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of Newborn Genetic Testing in EMEA by Types
  3.1.2 Revenue of Newborn Genetic Testing in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Newborn Genetic Testing in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Newborn Genetic Testing in EMEA by Downstream Industry
4.2 Demand Volume of Newborn Genetic Testing by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Newborn Genetic Testing by Downstream Industry in Europe
  4.2.2 Demand Volume of Newborn Genetic Testing by Downstream Industry in Middle East
  4.2.3 Demand Volume of Newborn Genetic Testing by Downstream Industry in Africa
4.3 Market Forecast of Newborn Genetic Testing in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEWBORN GENETIC TESTING

5.1 EMEA Economy Situation and Trend Overview
5.2 Newborn Genetic Testing Downstream Industry Situation and Trend Overview

CHAPTER 6 NEWBORN GENETIC TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of Newborn Genetic Testing in EMEA by Major Players
6.2 Revenue of Newborn Genetic Testing in EMEA by Major Players
6.3 Basic Information of Newborn Genetic Testing by Major Players
  6.3.1 Headquarters Location and Established Time of Newborn Genetic Testing Major Players
  6.3.2 Employees and Revenue Level of Newborn Genetic Testing Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 NEWBORN GENETIC TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Agilent Technologies
  7.1.1 Company profile
  7.1.2 Representative Newborn Genetic Testing Product
  7.1.3 Newborn Genetic Testing Sales, Revenue, Price and Gross Margin of Agilent Technologies
7.2 Bio-Rad Laboratories
  7.2.1 Company profile
  7.2.2 Representative Newborn Genetic Testing Product
  7.2.3 Newborn Genetic Testing Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories
7.3 Illumina
  7.3.1 Company profile
  7.3.2 Representative Newborn Genetic Testing Product
  7.3.3 Newborn Genetic Testing Sales, Revenue, Price and Gross Margin of Illumina
7.4 Sequenom
  7.4.1 Company profile
  7.4.2 Representative Newborn Genetic Testing Product
  7.4.3 Newborn Genetic Testing Sales, Revenue, Price and Gross Margin of Sequenom

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEWBORN GENETIC TESTING

8.1 Industry Chain of Newborn Genetic Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEWBORN GENETIC TESTING

9.1 Cost Structure Analysis of Newborn Genetic Testing
9.2 Raw Materials Cost Analysis of Newborn Genetic Testing
9.3 Labor Cost Analysis of Newborn Genetic Testing
9.4 Manufacturing Expenses Analysis of Newborn Genetic Testing

CHAPTER 10 MARKETING STATUS ANALYSIS OF NEWBORN GENETIC TESTING

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications